Market Briefing – 4 November 2026

🇸🇪 Svenska · 🇬🇧 English · 🇪🇸 Español

Marknadsskärmar med valurna, läkemedel, kinesisk konjunktur och ett skyddat AI-chip

AI-generated briefing. Facts and sources checked on 4 November 2026.

1. Democratic sweep jolts the AI trade

Democrats won majorities in both the US House and Senate in a midterm sweep that surprised markets. Nasdaq futures initially fell more than 2%, the Nikkei lost 3% and the US 10-year yield declined as investors priced in tighter technology rules, weaker government spending and political gridlock.

Why it matters: The new balance of power could slow data-centre construction, change tax and regulatory policy, and hit the global AI and semiconductor trade directly.

Source: Reuters, 4 November 2026

2. Novo Nordisk raises guidance after strong Wegovy pill sales

Novo Nordisk’s Wegovy pill generated DKK 5.39 billion in quarterly sales, well above the DKK 4.62 billion forecast. Adjusted operating profit rose 27% at constant exchange rates and the company raised its full-year sales and profit outlook.

Why it matters: The pill could restart growth and strengthen Novo against Eli Lilly, although US drug-pricing policy remains a clear risk.

Source: Reuters, 4 November 2026

3. Ambea beats profit forecast and starts integrating Humana

Ambea’s revenue rose 8% to SEK 4.45 billion, while adjusted EBITA increased 17% to SEK 668 million, 8% above analysts’ forecast. Earnings per share reached SEK 4.86 and the company has begun integration after acquiring 98% of Humana.

Why it matters: Higher occupancy and better margins strengthen the investment case, but Humana integration is the next major test for costs and execution.

Source: Placera · Ambea report archive

4. China’s services sector loses momentum

RatingDog’s private services PMI fell from 51.6 to 50.8 in October, the weakest expansion since July. Business confidence also deteriorated as competition and cost pressures increased.

Why it matters: Weaker services demand broadens China’s slowdown beyond manufacturing and may affect European exporters, luxury companies and commodity producers.

Source: Reuters, 4 November 2026

5. Moonshot releases Kimi with reduced hacking capability

Moonshot plans to release the weights of Kimi K3.1 Pro today after removing cyber-offensive training data. The model retains a one-million-token context window, but its score in an internal vulnerability test fell from 90.5% to 81.0% after the safety changes.

Why it matters: It is a concrete attempt to preserve the coding utility of an open model without also maximising its capacity for inexpensive cyberattacks.

Source: Reuters, 24 October 2026; release on 4 November